HANNA IDERBERG

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/med-hid?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2015
Mark Activity of serotonin 5-HT1A receptor 'biased agonists' in rat models of Parkinson's disease and l-DOPA-induced dyskinesia.
Iderberg, Hanna ^LU ; McCreary, A C ; Varney, M A ; Cenci Nilsson, Angela ^LU and Newman-Tancredi, A (2015) In Neuropharmacology 93. p.52-67
- Contribution to journal › Article
Mark NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
Iderberg, Hanna ^LU ; McCreary, A C ; Varney, M A ; Kleven, M S ; Koek, W ; Bardin, L ; Depoortère, R ; Cenci Nilsson, Angela ^LU and Newman-Tancredi, A (2015) In Experimental Neurology 271(May 30). p.335-350
- Contribution to journal › Article
Mark Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and l-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
Iderberg, Hanna ^LU ; Maslava, Natallia ^LU ; Thompson, Analisa D ; Bubser, Michael ; Niswender, Colleen M ; Hopkins, Corey R ; Lindsley, Craig W ; Conn, P Jeffrey ; Jones, Carrie K and Cenci Nilsson, Angela ^LU (2015) In Neuropharmacology 95. p.121-129
- Contribution to journal › Article
2014
Mark Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
Francardo, Veronica ^LU ; Iderberg, Hanna ^LU ; Lindgren, Hanna ^LU and Cenci Nilsson, Angela ^LU (2014) p.373-386
- Chapter in Book/Report/Conference proceeding › Book chapter
Mark Emerging pharmacotherapies for Parkinson's Disease: Experimental studies in the rat
Iderberg, Hanna ^LU (2014) In Lund University Faculty of Medicine Doctoral Dissertation Series 2014:144.
- Thesis › Doctoral thesis (compilation)
2013
Mark Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: Effects of combined treatment and possible mechanisms of action.
Iderberg, Hanna ^LU ; Rylander, Daniella ^LU ; Bimpisidis, Zisis ^LU and Cenci Nilsson, Angela ^LU (2013) In Experimental Neurology 250. p.116-124
- Contribution to journal › Article
2012
Mark Animal models of l-DOPA-induced dyskinesia: an update on the current options.
Iderberg, Hanna ^LU ; Francardo, Veronica ^LU and Pioli, E Y (2012) In Neuroscience 211. p.13-27
- Contribution to journal › Article
2011
Mark Putaminal Upregulation of FosB/Delta FosB-Like Immunoreactivity in Parkinson's Disease Patients with Dyskinesia
Lindgren, Hanna ^LU ; Rylander, Daniella ^LU ; Iderberg, Hanna ^LU ; Andersson, M. ; O'Sullivan, S. S. ; Williams, D. R. ; Lees, A. J. and Cenci Nilsson, Angela ^LU (2011) In Journal of Parkinson's Disease 1(4). p.347-357
- Contribution to journal › Article
2010
Mark A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys.
Rylander, Daniella ^LU ; Iderberg, Hanna ^LU ; Li, Qin ; Dekundy, Andrzej ; Zhang, Jinlan ; Li, Hao ; Baishen, Ren ; Danysz, Wojciech ; Bezard, Erwan and Cenci Nilsson, Angela ^LU (2010) In Neurobiology of Disease 39. p.352-361
- Contribution to journal › Article